Last update 02 May 2024
Dragonfly Therapeutics, Inc.

Dragonfly Therapeutics, Inc.

Startups
|
Holding Company|
2015|
Massachusetts, United States
|
100-250
|

Overview

Basic Info

Introduction
Dragonfly Therapeutics is a clinical-stage biotech developing novel first-in-class therapeutics targeted at natural killer cells and other cells of the innate immune system. These therapies are designed to counterbalance immune suppressive factors present in the tumor microenvironment and mobilize anti-cancer immune responses. The company's scientific founders are major figures in cancer biology and immunology and have launched Dragonfly to harness the power of the immune system to provide breakthrough cancer treatments for patients.

Tags

Neoplasms
Hemic and Lymphatic Diseases
Nervous System Diseases
Antibody
Biological products
CAR-NK

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Unknown11
Antibody2
Trispecific antibody1
Biological products1
CAR-NK1

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Jun 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
10
Preclinical
Phase 1 Clinical
3
3
Phase 2 Clinical
Other
5
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
DF6002
( IL-12 )
Squamous Cell Carcinoma of Head and Neck
More
Phase 2 Clinical
DF-1001
( CD16a x HER2 x NKG2D )
Solid tumor
More
Phase 2 Clinical
DF9001
( EGFR )
Solid tumor
More
Phase 2 Clinical
DF-8001
-
Phase 1
CC-96191
( CD33 )
Acute Myeloid Leukemia
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free